Company: HROW
Filing Date: 2025-11-10
Form Type: 10-Q
Source: 0001493152-25-021562
Chunk: 8

Company: HARROW, INC.
Filing Date: 2025-11-10
Form: 10-Q
Item: Item 1
Chunk 8
---
    Depreciation and amortization of property, plant and equipment and software development costs 
     1,451,000  
     1,382,000 
  
    Amortization of intangible assets 
     12,676,000  
     7,708,000 
  
    Non-cash lease expense 
     583,000  
     636,000 
  
    Provision for (recovery of) credit losses 
     548,000  
     (20,000)
  
    Amortization of debt issuance costs and debt discount 
     3,692,000  
     2,985,000 
  
    Investment loss from investment in Eton Pharmaceuticals 
     -  
     3,171,000 
  
    Loss on extinguishment of debt 
     7,750,000  
     - 
  
    Stock-based compensation 
     8,702,000  
     12,825,000 
  
    Deferred income tax 
     -  
     643,000 
  
    Changes in assets and liabilities: 

    Accounts receivable 
     38,225,000  
     (17,453,000)
  
    Inventories 
     (2,132,000) 
     711,000 
  
    Prepaid expenses and other current assets 
     2,449,000  
     (983,000)
  
    Accounts payable, accrued expenses, accrued rebates and copay assistance 
     (27,049,000) 
     6,433,000 
  
    Accrued payroll and related liabilities 
     22,000  
     1,735,000 
  
    Deferred revenue and customer deposits 
     301,000  
     62,000 
  
    NET CASH PROVIDED BY (USED IN) OPERATING ACTIVITIES 
     35,453,000  
     (4,423,000)
  
    CASH FLOWS FROM INVESTING ACTIVITIES 

    Net proceeds on sale of investment in Eton Pharmaceuticals 
     -  
     5,510,000 
  
    Investment in patent and trademark assets 
     (22,000) 
     (74,000)
  
    Purchase of product rights and related patents 
     (162,000) 

    Purchases of property, plant and